OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
23
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Publication Date
Release Date
2022
(4)
2021
(4)
2025
(3)
2023
(3)
2013
(2)
2011
(2)
2026
(1)
2020
(1)
2018
(1)
2017
(1)
2015
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Results of initial low-dose computed tomographic screening for lung cancer.
Not available
S-EPMC3762603
|
biostudies-literature
Cite
Safety of arthroscopic rotator cuff repair: using a core event set for clinician and patient assessment of risks in a multicenter cohort study.
Not available
S-EPMC12481389
|
biostudies-literature
Cite
Update of a prediction model for postoperative shoulder stiffness after arthroscopic rotator cuff repair.
Not available
S-EPMC12491454
|
biostudies-literature
Cite
Return to sport after arthroscopic rotator cuff repair: epidemiology and prognostic factors in a Swiss multicentre cohort.
Not available
S-EPMC12916472
|
biostudies-literature
Cite
Results of the two incidence screenings in the National Lung Screening Trial.
Not available
S-EPMC4307922
|
biostudies-literature
Cite
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Not available
S-EPMC4356534
|
biostudies-literature
Cite
The National Lung Screening Trial: overview and study design.
Not available
S-EPMC3009383
|
biostudies-literature
Cite
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Not available
S-EPMC9714135
|
biostudies-literature
Cite
Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema.
Not available
S-EPMC9896372
|
biostudies-literature
Cite
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Not available
S-EPMC5731244
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets